financetom
Business
financetom
/
Business
/
Insperity Swings to Q3 Adjusted Loss, Revenue Rises; Trims 2025 Adjusted Earnings Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Insperity Swings to Q3 Adjusted Loss, Revenue Rises; Trims 2025 Adjusted Earnings Guidance
Nov 4, 2025 1:12 AM

03:50 AM EST, 11/04/2025 (MT Newswires) -- Insperity ( NSP ) reported a Q3 adjusted loss late Monday of $0.20 per share, swinging from earnings of $0.39 a year earlier.

Analysts polled by FactSet expected earnings of $0.22.

Revenue for the quarter ended Sept. 30 was $1.62 billion, compared with $1.56 billion a year earlier.

Analysts polled by FactSet expected $1.63 billion.

The company expects a Q4 adjusted loss of $0.79 to $0.16 per share. Analysts polled by FactSet expect a loss of $0.33.

For 2025, the company trimmed its adjusted EPS guidance to $0.84 to $1.47 from $1.81 to $2.51 previously. Analysts polled by FactSet expect $1.37.

"We are pleased to announce a multi-year contract extension with UnitedHealthcare which provides significant cost reductions and reduces our pooling level for large claims to $500,000 beginning on January 1, 2026," said James D. Allison, executive vice president of finance and chief financial officer.

Shares of the company were down 31.3% in premarket activity Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX”
Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX”
Mar 11, 2026
PARAMUS, NJ, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics ( PLYX ) (“Polaryx” or the “Company”) a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), announced that shares of the Company’s common stock will start trading today on the Nasdaq Capital Market (“Nasdaq”) under the ticker...
Yext CEO Withdraws Non-Binding Acquisition Proposal; Company Intends to Repurchase $150 Million of Common Stock Through Self-Tender Offer
Yext CEO Withdraws Non-Binding Acquisition Proposal; Company Intends to Repurchase $150 Million of Common Stock Through Self-Tender Offer
Mar 11, 2026
NEW YORK--(BUSINESS WIRE)-- Yext, Inc. ( YEXT ) , the leading brand visibility platform, today announced that Michael Walrath, its Chief Executive Officer and Chairman of the Board of Directors, has withdrawn his previously announced proposal to acquire all outstanding shares of the Company not already owned by him at a price of $9.00 per share in cash. Mr. Walrath...
Nature's Miracle Holding Inc. Secures $5 Million Loan Backed by Ohio Property
Nature's Miracle Holding Inc. Secures $5 Million Loan Backed by Ohio Property
Mar 11, 2026
ONTARIO, Calif., Feb. 2, 2026 /PRNewswire/ -- Nature's Miracle Holding Inc. has finalized a $5 million loan with an institutional lender for its Toledo, Ohio commercial office property, owned through subsidiary Zak Properties LLC. The loan features an 8.5% interest rate, a two-year term, and includes an optional one-year extension. Funds from the loan will be used to pay off...
Park National Bank announces completion of First Citizens National Bank merger
Park National Bank announces completion of First Citizens National Bank merger
Mar 11, 2026
NEWARK, Ohio and DYERSBURG, Tenn., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Park National Corporation ( PRK ) (“Park”) announced that on February 1, 2026, it successfully completed its previously announced merger transaction with First Citizens Bancshares, Inc. (“First Citizens”) (OTCEM: FIZN) through an all-stock transaction. The merger combines two strong community-focused bank subsidiaries – Park National Bank and First Citizens...
Copyright 2023-2026 - www.financetom.com All Rights Reserved